Geode Capital Management
TXMD icon

Geode Capital Management’s TherapeuticsMD TXMD Stock Holding History

Geode Capital Management’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$222K Buy
109,817
+3,717
+4% +$8.36K ﹤0.01% 3873
2025
Q4 		$173K Sell
106,100
-2,983
-3% -$4.31K ﹤0.01% 3956
2025
Q3 		$116K Hold
109,083
– – ﹤0.01% 4093
2025
Q2 		$127K Sell
109,083
-2,425
-2% -$2.94K ﹤0.01% 4007
2025
Q1 		$103K Buy
111,508
+3,175
+3% +$3.16K ﹤0.01% 4024
2024
Q4 		$93.2K Hold
108,333
– – ﹤0.01% 4113
2024
Q3 		$180K Buy
108,333
+12,856
+13% +$22.4K ﹤0.01% 3936
2024
Q2 		$154K Buy
95,477
+10,689
+13% +$21.6K ﹤0.01% 4004
2024
Q1 		$194K Hold
84,788
– – ﹤0.01% 3949
2023
Q4 		$191K Hold
84,788
– – ﹤0.01% 3958
2023
Q3 		$256K Buy
84,788
+3,007
+4% +$11.4K ﹤0.01% 3880
2023
Q2 		$337K Hold
81,781
– – ﹤0.01% 3802
2023
Q1 		$307K Buy
81,781
+14,835
+22% +$71.2K ﹤0.01% 3852
2022
Q4 		$374K Buy
+66,946
New +$394K ﹤0.01% 3813
2022
Q3 		– Sell
-73,283
Closed -$729K – 5041
2022
Q2 		$729K Sell
73,283
-59,278
-45% -$566K ﹤0.01% 3562
2022
Q1 		$2.52M Buy
132,561
+2,211
+2% +$34.8K ﹤0.01% 3145
2021
Q4 		$2.32M Sell
130,350
-9,659
-7% -$289K ﹤0.01% 3298
2021
Q3 		$5.19M Buy
140,009
+16,409
+13% +$728K ﹤0.01% 2893
2021
Q2 		$7.35M Buy
123,600
+12,478
+11% +$756K ﹤0.01% 2669
2021
Q1 		$7.45M Buy
111,122
+35,043
+46% +$2.74M ﹤0.01% 2561
2020
Q4 		$4.6M Buy
76,079
+6,099
+9% +$416K ﹤0.01% 2647
2020
Q3 		$5.53M Sell
69,980
-1,416
-2% -$113K ﹤0.01% 2332
2020
Q2 		$4.46M Buy
71,396
+4,531
+7% +$264K ﹤0.01% 2400
2020
Q1 		$3.54M Buy
66,865
+6,596
+11% +$654K ﹤0.01% 2344
2019
Q4 		$7.29M Buy
60,269
+6,171
+11% +$887K ﹤0.01% 2227
2019
Q3 		$9.82M Buy
54,098
+693
+1% +$97.7K ﹤0.01% 1944
2019
Q2 		$6.94M Buy
53,405
+4,730
+10% +$848K ﹤0.01% 2181
2019
Q1 		$11.9M Buy
48,675
+4,551
+10% +$1.2M ﹤0.01% 1777
2018
Q4 		$8.4M Buy
44,124
+3,661
+9% +$893K ﹤0.01% 1889
2018
Q3 		$13.3M Buy
40,463
+4,316
+12% +$1.32M ﹤0.01% 1714
2018
Q2 		$11.3M Buy
36,147
+3,455
+11% +$1.06M ﹤0.01% 1787
2018
Q1 		$7.96M Buy
32,692
+556
+2% +$156K ﹤0.01% 1926
2017
Q4 		$9.7M Buy
32,136
+5,289
+20% +$1.47M ﹤0.01% 1765
2017
Q3 		$7.1M Buy
26,847
+715
+3% +$207K ﹤0.01% 1982
2017
Q2 		$6.88M Buy
26,132
+540
+2% +$135K ﹤0.01% 1920
2017
Q1 		$9.21M Buy
25,592
+2,353
+10% +$728K ﹤0.01% 1674
2016
Q4 		$6.7M Buy
23,239
+2,722
+13% +$843K ﹤0.01% 1862
2016
Q3 		$6.99M Buy
20,517
+255
+1% +$93.1K ﹤0.01% 1735
2016
Q2 		$8.61M Buy
20,262
+835
+4% +$344K ﹤0.01% 1547
2016
Q1 		$6.22K Buy
19,427
+2,543
+15% +$868K ﹤0.01% 1730
2015
Q4 		$8.75M Buy
16,884
+1,347
+9% +$497K 0.01% 1466
2015
Q3 		$4.55M Buy
15,537
+792
+5% +$282K ﹤0.01% 1897
2015
Q2 		$5.79M Buy
14,745
+1,363
+10% +$481K ﹤0.01% 1797
2015
Q1 		$4.05M Buy
13,382
+315
+2% +$76.9K ﹤0.01% 1986
2014
Q4 		$2.91M Buy
13,067
+1,042
+9% +$215K ﹤0.01% 2177
2014
Q3 		$2.79M Buy
12,025
+2,113
+21% +$532K ﹤0.01% 2157
2014
Q2 		$2.19M Buy
9,912
+285
+3% +$63.4K ﹤0.01% 2316
2014
Q1 		$3.04M Buy
9,627
+119
+1% +$37.9K ﹤0.01% 2088
2013
Q4 		$2.48M Buy
9,508
+6,044
+174% +$1.32M ﹤0.01% 2161
2013
Q3 		$507K Buy
3,464
+298
+9% +$36K ﹤0.01% 2941
2013
Q2 		$480K Buy
+3,166
New +$434K ﹤0.01% 2900

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management's TXMD Position: Q1 2026 in Review

Geode Capital Management increased its TherapeuticsMD (TXMD) stake by 3.5% in Q1 2026, buying an estimated $8.36K and bringing the position to 109,817 shares worth $222K. The position accounts for ﹤0.01% of the portfolio, ranked #3873.

Geode Capital Management first reported a position in TXMD in Q2 2013 and has held it in 51 quarters since. The position peaked at $13.3M in Q3 2018. 49 funds tracked by Wall St. Rank hold TXMD as of Q1 2026.

  • Geode Capital Management held 109,817 shares of TherapeuticsMD worth $222K as of Q1 2026.
  • Geode Capital Management bought 3,717 TherapeuticsMD shares in Q1 2026, an estimated $8.36K.
  • TherapeuticsMD made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3873 holding.
  • Geode Capital Management first reported a position in TherapeuticsMD in Q2 2013 and has held it in 51 quarters since.
  • Geode Capital Management's TherapeuticsMD position peaked at $13.3M in Q3 2018.
  • 49 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.